✦ LIBER ✦

Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?

✍ Scribed by Martin R Farlow

Book ID: 120715769
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 138 KB
Volume: 2
Category: Article
ISSN: 1758-9193
DOI: 10.1186/alzrt39

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of apoE genotyping as a pharmacogene

Use of apoE genotyping as a pharmacogenetic biomarker in phase II disease modification trials for Alzheimer's disease

✍ Stone, David J.; Molony, Cliona; Potter, William Z. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

0769 APOE genotype, lipids and risk for

0769 APOE genotype, lipids and risk for Alzheimer's disease in the Yoruba

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Donepezil Treatment and Alzheimer Diseas

Donepezil Treatment and Alzheimer Disease: Can the Results of Randomized Clinical Trials Be Applied to Alzheimer Disease Patients in Clinical Practice?

✍ Tinklenberg, Jared R.; Kraemer, Helena C.; Yaffe, Kristine; Ross, Leslie; Sheikh 📂 Article 📅 2007 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 146 KB

The Role of Biomarkers in Clinical Trial

The Role of Biomarkers in Clinical Trials for Alzheimer Disease

✍ Thal, Leon J; Kantarci, Kejal; Reiman, Eric M; Klunk, William E; Weiner, Michael 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 306 KB

Disease-modifying trial in Alzheimer's D

Disease-modifying trial in Alzheimer's Disease (AD): What should be the place of cognitive testing?

✍ Jacques Touchon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Effect of APOE genotype status on target

Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease

✍ Kennedy, Richard E.; Cutter, Gary R.; Schneider, Lon S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 418 KB